Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Elevance Health, Inc. Common Stock (NY:ELV)

286.43 -7.12 (-2.43%)
Streaming Delayed Price Updated: 12:24 PM EDT, Jul 31, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Elevance Health, Inc. Common Stock

< Previous 1 2
...
5 6 7 8 9 10 11 12 13
...
19 20 Next >
Insurance, Pharmacy Benefit Manager Company Stocks Drop Following UnitedHealth's Q4 Revenue Miss: What's Going On?
Shares of insurers and pharmacy benefit manager (PBM) companies such as Centene, Elevance Health, Humana and CVS Health are trading lower Thursday, likely in reaction to UnitedHealth Group's... 
Via Benzinga
Here's How Much $100 Invested In Elevance Health 20 Years Ago Would Be Worth Today
 
Via Benzinga
UnitedHealth Earnings Beat But Soft Revenue, Higher Costs Hit UNH Stock
The Dow giant earnings beat Q4 views, but revenue missed and medical costs ran high. 
Via Investor's Business Daily
Topics Earnings Stocks
Visualizing America’s $1.7 Trillion Insurance Industry
As of Jan. 7, 2025, UnitedHealth Group is the country’s most valuable insurance company, with a market cap of $473 billion. 
Via Talk Markets
Topics Stocks / Equities
A Closer Look at Elevance Health's Options Market Dynamics
 
Via Benzinga
If You Invested $100 In This Stock 20 Years Ago, You Would Have This Much Today
 
Via Benzinga
Peering Into Elevance Health's Recent Short Interest
 
Via Benzinga
What the Options Market Tells Us About Elevance Health
 
Via Benzinga
Breaking Down Elevance Health: 15 Analysts Share Their Views
 
Via Benzinga
Elevance Health to Hold Conference Call and Webcast to Discuss Fourth Quarter and Full Year 2024 Results on January 23, 2025
From Elevance Health, Inc.
Via Business Wire
Your Healthcare Costs are Soaring! US Spending Reached $5 Trillion In 2023 with Major Increase in Obesity and Diabetes Drugs, Hospital Services
U.S. healthcare spending grew 7.5% to $4.9 trillion in 2023, with hospital care and prescription drugs driving costs. Private insurance accounted for 30% of total spending. 
Via Benzinga
HCA Healthcare: 4 Reasons to Buy the 25% Dip
Discover why HCA Healthcare stock could be poised for a recovery despite recent setbacks, including hurricane-related expenses and claim denials. 
Via MarketBeat
Topics Government
Here's How Much You Would Have Made Owning Elevance Health Stock In The Last 15 Years
 
Via Benzinga
Decoding 11 Analyst Evaluations For Elevance Health
 
Via Benzinga
Robbins LLP Informs Elevance Health Inc. Stockholders that it is Investigating the Officers and Directors of ELV to Determine if They Breached Fiduciary Duties Owed to Shareholders
From Robbins LLP
Via GlobeNewswire
AM Best Affirms Credit Ratings of Elevance Health, Inc. and Its Subsidiaries
From AM Best
Via Business Wire
10 Health Care Stocks With Whale Alerts In Today's Session
 
Via Benzinga
UnitedHealth Stock Rises; Analyst Backs UnitedHealthcare Parent After CEO's Murder
UnitedHealth stock recovered some lost ground as Wall Street assesses whether the killing of the UnitedHealthcare insurance division CEO will hurt profitability. 
Via Investor's Business Daily
Elevance Health Stock Falls As Anthem Faces Backlash Over Anesthesia Policy, Announces Reversal
Anthem Blue Cross Blue Shield reverses a controversial policy limiting anesthesia reimbursements after backlash from medical professionals and state officials. 
Via Benzinga
Stock Market Hits Highs On Salesforce, Tech Earnings; Bitcoin Tops $100,000, Briefly: Weekly Review
Salesforce and mostly positive tech earnings buoyed the major indexes. 
Via Investor's Business Daily
10 Health Care Stocks Whale Activity In Today's Session
 
Via Benzinga
Deal Dispatch: Starbucks Considers China Sale, Private Equity Bankrupts Snack Company, Darwin Financial Talks Mining
Darwin Financial's Joshua Robinson talks to Benzinga about the firm's latest commodities deal, and more M&A news from this past week. 
Via Benzinga
Trump Picks Dr. Oz As Centers For Medicare And Medicaid Services Administrator
President-elect Donald Trump on Tuesday said that he will nominate celebrity physician Dr. Mehmet Oz to lead the Centers for Medicare & Medicaid Services (CMS). 
Via Benzinga
Topics Government
Deal Dispatch: Shell, Unilever And More Are On The Sell Side; The Onion Makes Alex Jones Cry Foul
Evolent Health, Kronos Bio, Saint-Gobain, Shell and Unilever are on the sell-side this week. Benzinga's Deal Dispatch has the latest M&A updates. 
Via Benzinga
Donald Trump's Second Term Could Reshape US Healthcare System, With Major Impacts on Affordable Care Act And Medicare
Trump's second term could bring significant changes to U.S. healthcare, with cuts to ACA subsidies and potential Medicare privatization. 
Via Benzinga
Topics Government
Elevance Health Announces Appearance at UBS Global Healthcare Conference
From Elevance Health, Inc.
Via Business Wire
Elevance Health Appoints Nathan Rich Vice President, Investor Relations
From Elevance Health, Inc.
Via Business Wire
What You Missed On Wall Street This Past Friday
Get caught up quickly on the top news and calls moving stocks with these five Top Five lists. 
Via Talk Markets
What the Earnings Miss Means For Elevance’s Future
A discussion about how you should react and how you should handle earnings announcements, especially when they are negative. 
Via Talk Markets
Topics Earnings
Cigna-Humana Merger Talks Back On With Tables Turned; 2024 Election Is Key
Cigna-Humana merger talks are back on, nearly one year after the first try. The price may be more affordable after CI stock outperformed, while HUM struggled. 
Via Investor's Business Daily
< Previous 1 2
...
5 6 7 8 9 10 11 12 13
...
19 20 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.